Diabetes: BD wins FDA nod for infusion set
Insulin Management
Diabetes: Debiotech takes out option on iSense
Switzerland’s Debiotech wants to blend continuous glucose monitoring technology made by an Oregon outfit into its JewelPump disposable insulin patch pump, a move toward a functioning artificial pancreas.
The Lausanne-based company announced an option to grab exclusive rights to CGM intellectual property developed by iSense CGM of Wilsonville, Ore.
Diabetes: Insulet extends OmniPod integration deal with Abbott
Novo Nordisk receives U.S. subpoena related to Danish factory
(Reuters) – Denmark’s Novo Nordisk , the world’s biggest maker of insulin, has received a U.S. subpoena requesting documents relating to potential manufacturing issues at its Kalundborg plant in Denmark, the company said on Friday.
Diabetes: Medtronic initiates IDE trial for new insulin management system
Diabetes: Medtronic study finds pumps beat injections for patient satisfaction
Insulin pumps beat manual injections for managing symptoms of Type 2 diabetes, according to the latest results from Medtronic’s (NYSE:MDT) OpT2mise clinical trials.
Diabetes: Medtronic warns on insulin pump overdose | MassDevice.com On Call
Diabetes and data: DexCom, Insulet share data in pursuit of app-based diabetes manager
Medtronic settles insulin pump beef for $2.8M
Diabetes: Miss Idaho’s on-stage insulin pump sparks frenzy | MassDevice.com On Call
MASSDEVICE ON CALL — Newly crowned Miss Idaho Sierra Sandison became a symbol for the Type I diabetes community after the beauty queen was seen on stage during the pageant sporting an insulin pump on her hip.
Sandison, who was diagnosed in 2012, called the decision to wear her insulin pump openly during the swimsuit competition a scary one, a sentiment shared by many who praised her on Twitter and other social media sites.
Diabetes: Medtronic insulin pump beats daily injections for managing Type II
In the largest study of its kind to date, researchers announced today that Medtronic’s (NYSE:MDT) MiniMed insulin pump beat multiple daily injections in managing blood glucose levels in patients with Type II diabetes.
